Biallelic CACNA1A variants: Review of literature and report of a child with drug‐resistant epilepsy and developmental delay

Biallelic variants in CACNA1A have previously been reported in nine individuals (four families) presenting with epilepsy and cognitive impairments of variable severity and age‐of‐onset. Here, we describe a child who presented at 6 months of age with drug‐resistant epilepsy and developmental delay. A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of medical genetics. Part A 2022-11, Vol.188 (11), p.3306-3311
Hauptverfasser: Wong‐Spracklen, Vivien M. Y., Kolesnik, Anna, Eck, Josefine, Sabanathan, Saras, Spasic‐Boskovic, Olivera, Maw, Anna, Baker, Kate
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3311
container_issue 11
container_start_page 3306
container_title American journal of medical genetics. Part A
container_volume 188
creator Wong‐Spracklen, Vivien M. Y.
Kolesnik, Anna
Eck, Josefine
Sabanathan, Saras
Spasic‐Boskovic, Olivera
Maw, Anna
Baker, Kate
description Biallelic variants in CACNA1A have previously been reported in nine individuals (four families) presenting with epilepsy and cognitive impairments of variable severity and age‐of‐onset. Here, we describe a child who presented at 6 months of age with drug‐resistant epilepsy and developmental delay. At 10 years of age, she has profound impairments in motor function and communication. MRI was initially unremarkable, but progressed to severe cerebellar atrophy by age 3 years. Next Generation Sequencing and panel analysis identified a maternally inherited truncating variant c.2042_2043delAG, p.(Gln681ArgfsTer100) and paternally inherited missense variant c.1693G>A, p.(Glu565Lys). In contrast to previously reported biallelic cases, parents carrying these monoallelic variants did not display clear signs of a CACNA1A‐associated syndrome. In conclusion, we provide further evidence that biallelic CACNA1A variants can cause a severe epileptic and developmental encephalopathy with progressive cerebellar atrophy, and highlight complexities of genetic counseling in such situations.
doi_str_mv 10.1002/ajmg.a.62960
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9826308</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2709915625</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4570-d110a7f7c0bc173732f085472720f249ab2d60479ec6875d502289f38139583b3</originalsourceid><addsrcrecordid>eNp9kc-O0zAQhy0EYpeFG2dkiQsHWvwntmMOSKGCBbSAhOBsucmkdeXEwU5a9YDEI_CMPAnudqmAAyfbms-fZuaH0ENK5pQQ9sxuutXcziXTktxC51QINitKzm-f7kycoXspbQjhRCh5F51xSSSntDhH31466z14V-NFtfhQ0QpvbXS2H9Nz_Am2DnY4tNi7EaIdpwjY9g2OMIQ4HgoW12vnG7xz4xo3cVr9_P4jQnJpzAoMg_MwpP31pwa24MPQQT9an1_e7u-jO631CR7cnBfoy-tXnxdvZlcfL98uqqtZXQhFZg2lxKpW1WRZU8UVZy0pRaGYYqRlhbZL1khSKA21LJVoBGGs1C0vKdei5Et-gV4cvcO07KCpcwvRejNE19m4N8E683eld2uzClujSyY5KbPgyY0ghq8TpNF0LtXgve0hTMkwRbSmQjKR0cf_oJswxT6PlynGVCGpPgifHqk6hpQitKdmKDGHXM0hV2PNda4Zf_TnACf4d5AZKI7ALm98_1-Zqd69v6yO3l_xg7Az</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2722746198</pqid></control><display><type>article</type><title>Biallelic CACNA1A variants: Review of literature and report of a child with drug‐resistant epilepsy and developmental delay</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Wong‐Spracklen, Vivien M. Y. ; Kolesnik, Anna ; Eck, Josefine ; Sabanathan, Saras ; Spasic‐Boskovic, Olivera ; Maw, Anna ; Baker, Kate</creator><creatorcontrib>Wong‐Spracklen, Vivien M. Y. ; Kolesnik, Anna ; Eck, Josefine ; Sabanathan, Saras ; Spasic‐Boskovic, Olivera ; Maw, Anna ; Baker, Kate</creatorcontrib><description>Biallelic variants in CACNA1A have previously been reported in nine individuals (four families) presenting with epilepsy and cognitive impairments of variable severity and age‐of‐onset. Here, we describe a child who presented at 6 months of age with drug‐resistant epilepsy and developmental delay. At 10 years of age, she has profound impairments in motor function and communication. MRI was initially unremarkable, but progressed to severe cerebellar atrophy by age 3 years. Next Generation Sequencing and panel analysis identified a maternally inherited truncating variant c.2042_2043delAG, p.(Gln681ArgfsTer100) and paternally inherited missense variant c.1693G&gt;A, p.(Glu565Lys). In contrast to previously reported biallelic cases, parents carrying these monoallelic variants did not display clear signs of a CACNA1A‐associated syndrome. In conclusion, we provide further evidence that biallelic CACNA1A variants can cause a severe epileptic and developmental encephalopathy with progressive cerebellar atrophy, and highlight complexities of genetic counseling in such situations.</description><identifier>ISSN: 1552-4825</identifier><identifier>EISSN: 1552-4833</identifier><identifier>DOI: 10.1002/ajmg.a.62960</identifier><identifier>PMID: 36063114</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Age ; Atrophy ; Atrophy - complications ; biallelic ; CACNA1A ; Calcium Channels - genetics ; Case Report ; Case Reports ; cerebellar atrophy ; Cerebellum ; Child ; Child, Preschool ; Cognitive ability ; Drug resistance ; Drug Resistant Epilepsy ; Encephalopathy ; Epilepsy ; Epilepsy - diagnosis ; Epilepsy - drug therapy ; Epilepsy - genetics ; epileptic encephalopathy ; Family ; Female ; Genetic counseling ; Humans ; intellectual disability ; Mutation, Missense ; Next-generation sequencing ; recessive</subject><ispartof>American journal of medical genetics. Part A, 2022-11, Vol.188 (11), p.3306-3311</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC.</rights><rights>2022 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4570-d110a7f7c0bc173732f085472720f249ab2d60479ec6875d502289f38139583b3</citedby><cites>FETCH-LOGICAL-c4570-d110a7f7c0bc173732f085472720f249ab2d60479ec6875d502289f38139583b3</cites><orcidid>0000-0003-2986-0584</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajmg.a.62960$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajmg.a.62960$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36063114$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wong‐Spracklen, Vivien M. Y.</creatorcontrib><creatorcontrib>Kolesnik, Anna</creatorcontrib><creatorcontrib>Eck, Josefine</creatorcontrib><creatorcontrib>Sabanathan, Saras</creatorcontrib><creatorcontrib>Spasic‐Boskovic, Olivera</creatorcontrib><creatorcontrib>Maw, Anna</creatorcontrib><creatorcontrib>Baker, Kate</creatorcontrib><title>Biallelic CACNA1A variants: Review of literature and report of a child with drug‐resistant epilepsy and developmental delay</title><title>American journal of medical genetics. Part A</title><addtitle>Am J Med Genet A</addtitle><description>Biallelic variants in CACNA1A have previously been reported in nine individuals (four families) presenting with epilepsy and cognitive impairments of variable severity and age‐of‐onset. Here, we describe a child who presented at 6 months of age with drug‐resistant epilepsy and developmental delay. At 10 years of age, she has profound impairments in motor function and communication. MRI was initially unremarkable, but progressed to severe cerebellar atrophy by age 3 years. Next Generation Sequencing and panel analysis identified a maternally inherited truncating variant c.2042_2043delAG, p.(Gln681ArgfsTer100) and paternally inherited missense variant c.1693G&gt;A, p.(Glu565Lys). In contrast to previously reported biallelic cases, parents carrying these monoallelic variants did not display clear signs of a CACNA1A‐associated syndrome. In conclusion, we provide further evidence that biallelic CACNA1A variants can cause a severe epileptic and developmental encephalopathy with progressive cerebellar atrophy, and highlight complexities of genetic counseling in such situations.</description><subject>Age</subject><subject>Atrophy</subject><subject>Atrophy - complications</subject><subject>biallelic</subject><subject>CACNA1A</subject><subject>Calcium Channels - genetics</subject><subject>Case Report</subject><subject>Case Reports</subject><subject>cerebellar atrophy</subject><subject>Cerebellum</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cognitive ability</subject><subject>Drug resistance</subject><subject>Drug Resistant Epilepsy</subject><subject>Encephalopathy</subject><subject>Epilepsy</subject><subject>Epilepsy - diagnosis</subject><subject>Epilepsy - drug therapy</subject><subject>Epilepsy - genetics</subject><subject>epileptic encephalopathy</subject><subject>Family</subject><subject>Female</subject><subject>Genetic counseling</subject><subject>Humans</subject><subject>intellectual disability</subject><subject>Mutation, Missense</subject><subject>Next-generation sequencing</subject><subject>recessive</subject><issn>1552-4825</issn><issn>1552-4833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp9kc-O0zAQhy0EYpeFG2dkiQsHWvwntmMOSKGCBbSAhOBsucmkdeXEwU5a9YDEI_CMPAnudqmAAyfbms-fZuaH0ENK5pQQ9sxuutXcziXTktxC51QINitKzm-f7kycoXspbQjhRCh5F51xSSSntDhH31466z14V-NFtfhQ0QpvbXS2H9Nz_Am2DnY4tNi7EaIdpwjY9g2OMIQ4HgoW12vnG7xz4xo3cVr9_P4jQnJpzAoMg_MwpP31pwa24MPQQT9an1_e7u-jO631CR7cnBfoy-tXnxdvZlcfL98uqqtZXQhFZg2lxKpW1WRZU8UVZy0pRaGYYqRlhbZL1khSKA21LJVoBGGs1C0vKdei5Et-gV4cvcO07KCpcwvRejNE19m4N8E683eld2uzClujSyY5KbPgyY0ghq8TpNF0LtXgve0hTMkwRbSmQjKR0cf_oJswxT6PlynGVCGpPgifHqk6hpQitKdmKDGHXM0hV2PNda4Zf_TnACf4d5AZKI7ALm98_1-Zqd69v6yO3l_xg7Az</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Wong‐Spracklen, Vivien M. Y.</creator><creator>Kolesnik, Anna</creator><creator>Eck, Josefine</creator><creator>Sabanathan, Saras</creator><creator>Spasic‐Boskovic, Olivera</creator><creator>Maw, Anna</creator><creator>Baker, Kate</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2986-0584</orcidid></search><sort><creationdate>202211</creationdate><title>Biallelic CACNA1A variants: Review of literature and report of a child with drug‐resistant epilepsy and developmental delay</title><author>Wong‐Spracklen, Vivien M. Y. ; Kolesnik, Anna ; Eck, Josefine ; Sabanathan, Saras ; Spasic‐Boskovic, Olivera ; Maw, Anna ; Baker, Kate</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4570-d110a7f7c0bc173732f085472720f249ab2d60479ec6875d502289f38139583b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Atrophy</topic><topic>Atrophy - complications</topic><topic>biallelic</topic><topic>CACNA1A</topic><topic>Calcium Channels - genetics</topic><topic>Case Report</topic><topic>Case Reports</topic><topic>cerebellar atrophy</topic><topic>Cerebellum</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cognitive ability</topic><topic>Drug resistance</topic><topic>Drug Resistant Epilepsy</topic><topic>Encephalopathy</topic><topic>Epilepsy</topic><topic>Epilepsy - diagnosis</topic><topic>Epilepsy - drug therapy</topic><topic>Epilepsy - genetics</topic><topic>epileptic encephalopathy</topic><topic>Family</topic><topic>Female</topic><topic>Genetic counseling</topic><topic>Humans</topic><topic>intellectual disability</topic><topic>Mutation, Missense</topic><topic>Next-generation sequencing</topic><topic>recessive</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wong‐Spracklen, Vivien M. Y.</creatorcontrib><creatorcontrib>Kolesnik, Anna</creatorcontrib><creatorcontrib>Eck, Josefine</creatorcontrib><creatorcontrib>Sabanathan, Saras</creatorcontrib><creatorcontrib>Spasic‐Boskovic, Olivera</creatorcontrib><creatorcontrib>Maw, Anna</creatorcontrib><creatorcontrib>Baker, Kate</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of medical genetics. Part A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wong‐Spracklen, Vivien M. Y.</au><au>Kolesnik, Anna</au><au>Eck, Josefine</au><au>Sabanathan, Saras</au><au>Spasic‐Boskovic, Olivera</au><au>Maw, Anna</au><au>Baker, Kate</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biallelic CACNA1A variants: Review of literature and report of a child with drug‐resistant epilepsy and developmental delay</atitle><jtitle>American journal of medical genetics. Part A</jtitle><addtitle>Am J Med Genet A</addtitle><date>2022-11</date><risdate>2022</risdate><volume>188</volume><issue>11</issue><spage>3306</spage><epage>3311</epage><pages>3306-3311</pages><issn>1552-4825</issn><eissn>1552-4833</eissn><abstract>Biallelic variants in CACNA1A have previously been reported in nine individuals (four families) presenting with epilepsy and cognitive impairments of variable severity and age‐of‐onset. Here, we describe a child who presented at 6 months of age with drug‐resistant epilepsy and developmental delay. At 10 years of age, she has profound impairments in motor function and communication. MRI was initially unremarkable, but progressed to severe cerebellar atrophy by age 3 years. Next Generation Sequencing and panel analysis identified a maternally inherited truncating variant c.2042_2043delAG, p.(Gln681ArgfsTer100) and paternally inherited missense variant c.1693G&gt;A, p.(Glu565Lys). In contrast to previously reported biallelic cases, parents carrying these monoallelic variants did not display clear signs of a CACNA1A‐associated syndrome. In conclusion, we provide further evidence that biallelic CACNA1A variants can cause a severe epileptic and developmental encephalopathy with progressive cerebellar atrophy, and highlight complexities of genetic counseling in such situations.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>36063114</pmid><doi>10.1002/ajmg.a.62960</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-2986-0584</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-4825
ispartof American journal of medical genetics. Part A, 2022-11, Vol.188 (11), p.3306-3311
issn 1552-4825
1552-4833
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9826308
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Age
Atrophy
Atrophy - complications
biallelic
CACNA1A
Calcium Channels - genetics
Case Report
Case Reports
cerebellar atrophy
Cerebellum
Child
Child, Preschool
Cognitive ability
Drug resistance
Drug Resistant Epilepsy
Encephalopathy
Epilepsy
Epilepsy - diagnosis
Epilepsy - drug therapy
Epilepsy - genetics
epileptic encephalopathy
Family
Female
Genetic counseling
Humans
intellectual disability
Mutation, Missense
Next-generation sequencing
recessive
title Biallelic CACNA1A variants: Review of literature and report of a child with drug‐resistant epilepsy and developmental delay
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T18%3A43%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biallelic%20CACNA1A%20variants:%20Review%20of%20literature%20and%20report%20of%20a%20child%20with%20drug%E2%80%90resistant%20epilepsy%20and%20developmental%20delay&rft.jtitle=American%20journal%20of%20medical%20genetics.%20Part%20A&rft.au=Wong%E2%80%90Spracklen,%20Vivien%20M.%20Y.&rft.date=2022-11&rft.volume=188&rft.issue=11&rft.spage=3306&rft.epage=3311&rft.pages=3306-3311&rft.issn=1552-4825&rft.eissn=1552-4833&rft_id=info:doi/10.1002/ajmg.a.62960&rft_dat=%3Cproquest_pubme%3E2709915625%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2722746198&rft_id=info:pmid/36063114&rfr_iscdi=true